 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Benitec Looks to Outlicense IP While Avoiding Litigation Mistakes of Its Past
November 08, 2012
Benitec Looks to Outlicense IP While Avoiding Litigation Mistakes of Its Past
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Benitec Provides Pipeline Update Following Tacere Acquisition
October 18, 2012 / Gene Silencing News - With Drugs in the Clinic, Gradalis Starts Looking to Partner Its Technologies
October 11, 2012 / Gene Silencing News - Benitec Says USPTO Poised to Finalize Validity Ruling for Key Patent
February 17, 2011 / Gene Silencing News - Benitec Says European Patent Forthcoming on HCV Inhibition Technology
December 16, 2010 / Gene Silencing News - Benitec Says USPTO Reverses Rejection of US Patent
September 30, 2010 / Gene Silencing News